Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-10 Sale |
2025-02-12 5:16 pm |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
3,777 | $15.5 | $58,559 | 90,746 (Direct) |
View |
| 2024-06-14 Purchase |
2024-06-17 09:26 am |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
1,250 | $20.03 | $25,037 | 52,623 (Direct) |
View |
| 2023-06-13 Sale |
2023-06-14 4:20 pm |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
577 | $22.31 | $12,873 | 2,628 (Direct) |
View |
| 2022-03-16 Sale |
2022-03-17 1:23 pm |
OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer |
4,617 | $2.11 | $9,742 | 141,726 (Direct) |
View |
| 2021-12-16 Sale |
2021-12-17 09:27 am |
OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer |
580 | $1.64 | $951 | 89,613 (Direct) |
View |
| 2021-09-16 Sale |
2021-09-17 1:53 pm |
OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer |
578 | $2.789 | $1,612 | 90,193 (Direct) |
View |
| 2021-06-17 Sale |
2021-06-17 6:35 pm |
OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer |
576 | $3.73 | $2,148 | 90,771 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 6:11 pm |
OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer |
2,304 | $3.92 | $9,032 | 91,347 (Direct) |
View |
| 2020-09-23 Purchase |
2020-09-23 4:47 pm |
OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer |
2,500 | $3.897 | $9,743 | 9,751 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-05 Option Award |
2025-02-07 4:44 pm |
N/A 2035-02-05 |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
110,500 | $14.65 | 205,023 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-07 4:44 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
41,900 | $0 | 205,023 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:05 pm |
N/A 2034-02-07 |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
70,000 | $22.28 | 123,418 (Direct) |
View |
| 2024-01-31 Other |
2024-02-09 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
1,183 | $17.42 | 123,418 (Direct) |
View |
| 2023-07-31 Other |
2024-02-09 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
862 | $18.12 | 123,418 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:05 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
46,700 | $0 | 123,418 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:00 pm |
N/A 2033-02-02 |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
110,000 | $28.55 | 110,000 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 4:12 pm |
N/A 2032-06-13 |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
230,000 | $15.6 | 233,205 (Direct) |
View |
| 2022-06-13 Option Award |
2022-06-15 4:12 pm |
N/A N/A |
Syndax Pharmaceuticals Inc | SNDX | Goldan Keith A. Chief Financial Officer |
3,205 | $0 | 233,205 (Direct) |
View |
| 2022-01-11 Option Award |
2022-01-12 4:02 pm |
N/A 2032-01-11 |
OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer |
208,010 | $0 | 297,623 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 5:19 pm |
N/A 2031-03-04 |
OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer |
80,000 | $3.51 | 143,084 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 5:19 pm |
N/A N/A |
OptiNose Inc. | OPTN | Goldan Keith A. Chief Financial Officer |
53,333 | $0 | 143,084 (Direct) |
View |